AP
1136 drugs in development·378 companies·1 clinical trial
Drug Pipeline by Phase
Approved(393)
Phase 3(184)
Phase 2(164)
Phase 1(114)
Preclinical(62)
Unknown(95)
BLA Filed(2)
Early Phase 1(1)
N/A(8)
Phase 1/Phase 2(69)
Phase 2/Phase 3(6)
Phase 4(38)
Compare drugs
Frequently asked questions
How many drugs are in development for AP?
BioSniper tracks 1136 drugs in development for AP across 378 companies.
How many clinical trials target AP?
There are 1 clinical trial targeting AP tracked by BioSniper.
Analyze ImmunityBio, Inc.'s AP pipeline with AI
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start AI Analysis